RSC Medicinal Chemistry, volume 14, issue 2, pages 253-267
Anticancer evaluation of new organometallic ruthenium(ii ) flavone complexes
2
Therapeutic Chemistry Department, Pharmaceutical & Drug Industries Research Division, National Research Centre, Cairo, Egypt
|
Publication type: Journal Article
Publication date: 2023-01-01
Journal:
RSC Medicinal Chemistry
Quartile SCImago
Q1
Quartile WOS
Q2
Impact factor: 4.1
ISSN: 26328682
Organic Chemistry
Drug Discovery
Biochemistry
Pharmacology
Pharmaceutical Science
Molecular Medicine
Abstract
Targeting multiple malignancy features such as angiogenesis, proliferation and metastasis with one molecule is an effective strategy in developing potent anticancer agents.
Top-30
Journals
|
1
2
|
|
|
Dalton Transactions
2 publications, 15.38%
|
|
|
Inorganic Chemistry
2 publications, 15.38%
|
|
|
Molecules
1 publication, 7.69%
|
|
|
Comments on Inorganic Chemistry
1 publication, 7.69%
|
|
|
Frontiers in Pharmacology
1 publication, 7.69%
|
|
|
Nucleic Acids Research
1 publication, 7.69%
|
|
|
Coordination Chemistry Reviews
1 publication, 7.69%
|
|
|
Journal of Molecular Liquids
1 publication, 7.69%
|
|
|
Royal Society Open Science
1 publication, 7.69%
|
|
|
Russian Chemical Reviews
1 publication, 7.69%
|
|
|
1
2
|
Publishers
|
1
2
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 15.38%
|
|
|
Elsevier
2 publications, 15.38%
|
|
|
American Chemical Society (ACS)
2 publications, 15.38%
|
|
|
MDPI
1 publication, 7.69%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 7.69%
|
|
|
Taylor & Francis
1 publication, 7.69%
|
|
|
Frontiers Media S.A.
1 publication, 7.69%
|
|
|
Oxford University Press
1 publication, 7.69%
|
|
|
The Royal Society
1 publication, 7.69%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 7.69%
|
|
|
1
2
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Khater M. et al. Anticancer evaluation of new organometallic ruthenium(ii) flavone complexes // RSC Medicinal Chemistry. 2023. Vol. 14. No. 2. pp. 253-267.
GOST all authors (up to 50)
Copy
Khater M., Brazier J. A., Greco F., OSBORN H. Anticancer evaluation of new organometallic ruthenium(ii) flavone complexes // RSC Medicinal Chemistry. 2023. Vol. 14. No. 2. pp. 253-267.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1039/d2md00304j
UR - https://doi.org/10.1039/d2md00304j
TI - Anticancer evaluation of new organometallic ruthenium(ii) flavone complexes
T2 - RSC Medicinal Chemistry
AU - Khater, Mai
AU - Brazier, John A
AU - Greco, Francesca
AU - OSBORN, HELEN
PY - 2023
DA - 2023/01/01
PB - Royal Society of Chemistry (RSC)
SP - 253-267
IS - 2
VL - 14
SN - 2632-8682
ER -
Cite this
BibTex
Copy
@article{2023_Khater,
author = {Mai Khater and John A Brazier and Francesca Greco and HELEN OSBORN},
title = {Anticancer evaluation of new organometallic ruthenium(ii) flavone complexes},
journal = {RSC Medicinal Chemistry},
year = {2023},
volume = {14},
publisher = {Royal Society of Chemistry (RSC)},
month = {jan},
url = {https://doi.org/10.1039/d2md00304j},
number = {2},
pages = {253--267},
doi = {10.1039/d2md00304j}
}
Cite this
MLA
Copy
Khater, Mai, et al. “Anticancer evaluation of new organometallic ruthenium(ii) flavone complexes.” RSC Medicinal Chemistry, vol. 14, no. 2, Jan. 2023, pp. 253-267. https://doi.org/10.1039/d2md00304j.